baber/WOPTO huggingface dataset:
Patent NZ-534751-A (NZ)
Title: Method of visualizing non-targeted metabolomic data generated from fourier transform ion cyclotron resonance mass spectrometers
Inventor: HEATH DOUGLAS
IPC: G16B45/00
Filed: 2003-03-20
Abstract: Mass spectrometric data from a plurality of samples each containing a plurality of components is obtained, and each of the components is labelled with a primary ordered pair (X,Y), X being a data element value equivalent or directly proportional to the mass of a component, and Y being a data element value equivalent to or directly proportional to the amount of the component. Each of the components is labelled with one or more secondary data elements of other identifying data, and all of the unique components comprising a common data element value X are identified in the samples. In order to visualise the data, a primary two dimensional data structure comprising a plurality of codable cells is generated and displayed, in which one axis is defined by a list of unique components comprising common data element value X, the other axis is defined by the source of the component of the sample and wherein each cell defined by a given horizontal or vertical coordinate within the data structure contains information specifically related to unique component X with the parameters defined by Y.
Patent NZ-543748-A (NZ)
Title: Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors)
Inventor: FREYEN EDDY JEAN EDGARD
Filed: 2002-10-29
Abstract: Disclosed are compounds of formula (I), wherein the substituents R1, R2, R3, R4, X, Z and s are as defined in the specification. These compounds are used in the manufacture of medicaments for the treatment of diseases mediated through glycogen synthase kinase 3 (GSK3).
Patent NZ-549264-A (NZ)
Title: Pharmaceutical formulations containing ammonio methacrylate copolymers
Inventor: BROWN ADRIAN
IPC: A61K9/50
Filed: 2005-03-11
Abstract: Disclosed is a capsule having a shell wall, a generally cylindrical linker or subunit, each being composed of an extruded and injection molded material comprising a pharmaceutically acceptable composition comprising (i) a copolymer of Ammonio Methacrylate Copolymer Type A or Ammonio Methacrylate Copolymer Type B present in an amount of about 10 to about 80% w/w; (ii) at least one dissolution modifying excipient which is a first swellable solid selected from hydroxypropyl cellulose present in an amount of about 20 to about 65% w/w; optionally in combination with a second dissolution modifying excipient group consisting of a) a second swellable solid selected from ethyl cellulose, cellulose acetate phthalate; hydroxypropyl cellulose of differing molecular weight, hydroxypropylmethyl cellulose, hydroxypropylmethyl cellulose phthalate, and combinations or mixtures thereof; b) a disintegrant selected from sodium starch glycollate, croscarmellose sodium, crospovidone (cross-linked polyvinyl pyrrolidone), copovidone, polyvinyl pyrrolidone; and combinations or mixtures thereof present in an amount of about 10 to 40%; c) a water soluble filler selected from lactose, lactitol, maltitol, sorbitol or an organic acids selected from malic acid, citric acid or succinic acid, present in the amount of about 5 to about 70% w/w; or d) a non-reducing sugar selected from xylitol, or mannitol present in the range of about 2.5 to about 15% w/w; (iii) a lubricant selected from stearyl alcohol, stearic acid, glycerol monostearate (GMS), talc, magnesium stearate, silicon dioxide, amorphous silicic acid, and fumed silica; and combinations or mixtures thereof present in an amount of about 5% to about 25% w/w; (iv) optionally a surfactant selected from the group consisting of block copolymers of ethylene oxide and propylene oxide, lecithin, sodium dioctyl sulfosuccinate, sodium dodecyl sulfate, polyoxyl 40 hydrogenated castor oil, polyoxyethylene sorbitan fatty acid esters, sorbitan fatty acid esters, polyethylene glycol, d-alpha-tocopheryl polyethylene glycol 1000 succinate, sucrose fatty acid esters, and combinations and mixtures thereof present in an amount of 0 to 10%; (v) optionally a plasticizer selected from triethyl citrate (TEC), triacetin, tributyl citrate, acetyl triethyl citrate (ATEC), acetyl tributyl citrate (ATBC), dibutyl phthalate, dibutyl sebacate (DBS), diethyl phthalate, vinyl pyrrolidone glycol triacetate, polyethylene glycol, polyoxyethylene sorbitan monolaurate, propylene glycol, or castor oil, and combinations or mixtures thereof present in an amount of 0 to 10% ; and (vi) optionally a processing agent which is talc present in an amount of 0 to about 10% w/w; and wherein the shell wall, the linker or subunit are 5 comprised of the pharmaceutical composition.
Patent NZ-561610-A (NZ)
Title: Method and system for laser marking in the volume of gemstones such as diamonds
Inventor: BARRON WES
IPC: A44C17/00
Filed: 2005-08-26
Abstract: Three methods for adaptive control of the creation of indicia in the bulk of a gemstone specimen are disclosed. The methods include using a series of laser pulses in the femtosecond range focused below the surface of the specimen. The indicia identify the specimen without affecting the surface of the specimen and are invisible under 10X magnification. The first method comprises: predetermining characterising features of the indicia to be created; executing a predetermined marking protocol for the series of laser pulses using parameters selected from among the group comprising wavelength, pulse duration, number of pulses, repetition rate, energy per pulse, numerical aperture of focusing optics and target coordinates; automatically monitoring the creation of the indicia as the protocol is being executed; and automatically interrupting further execution of the protocol when the monitoring reveals that the indicia exhibits the characterising features. The second method comprises: generating an identification code for association with the specimen; determining a characteristic pattern for a plurality of indicia corresponding to the identification code; and executing a marking protocol for the series of laser pulses by applying the pulses to attempt to sequentially create each of the indicia according to the characteristic pattern. If execution of the protocol creates one but not all of the indicia according to the characteristic pattern, the method includes generating a new identification code corresponding to a new characteristic pattern that is consistent with those of the indicia that have been successfully created, and if required executing a marking protocol to create additional indicia to attempt to complete the new characteristic pattern. The third method comprises: establishing a marking protocol for an ultrashort laser pulse marking system comprising a plurality of predetermined sets of parameters, each set comprising parameters selected from among the group comprising wavelength, pulse duration, number of pulses, repetition rate, energy per pulse, numerical aperture of focusing optics, and target coordinates; attempting to create an indicium by executing a first set of parameters determined by the protocol; and automatically assessing whether an indicium was created using the first set of parameters. If an indicium was not created, the method includes automatically attempting to create an indicium according to a second set of parameters predetermined by the protocol.
Patent NZ-564792-A (NZ)
Title: Pet litter box
Inventor: KRATZER OLIVER CLEMENS ROBERT
IPC: A01K1/01
Filed: 2006-07-10
Abstract: A pet litter device which includes a tray to contain pet litter, a pivoting lifting handle connected to the tray to assist in emptying used pet litter, a ramp connectable to the tray to allow ingress and egress to the tray, a skirt adapted to be attached to the perimeter of the tray and having an opening corresponding to the position of the ramp plus an optional sifting scoop for removing pet litter detachably mounted on the underside of the ramp. The upper surface of the ramp is covered in a fabric that cleans the paws of the pet. The pivoting handle, spans the width of the tray and is foldable to encompass one end of the tray, and a single fixed handle is provided at the other end of the tray and the ramp clamps onto the fixed handle. The skirt ramp and scoop are injection moulded together and are detachably connected together prior to assembly with the tray. The injection moulded skirt ramp and scoop nest with the tray prior to assembly for ease of storage and display in retail outlets.
Patent NZ-565852-A (NZ)
Title: Low PH aerated products
Inventor: COX ANDREW RICHARD
IPC: A23L19/00
Filed: 2006-09-13
Abstract: Disclosed is an aerated composition having a pH of less than 5.5, which composition comprises hydrophobin. Also disclosed is the use of hydrophobin in a method to inhibit bubble coarsening or stabilise the foam in said composition
Patent NZ-567706-A (NZ)
Title: Cogeneration systems and processes for treating hydrocarbon containing formations
Inventor: FOWLER THOMAS DAVID
IPC: E21B36/04
Filed: 2006-10-20
Abstract: A system for treating a hydrocarbon containing formation is disclosed. The system comprises: (a) a steam and electricity cogeneration facility; (b) at least one injection well located in a first portion of the formation where the injection well is configured to provide steam from the steam and electricity cogeneration facility to the first portion of the formation; (c) at least one production well located in the first portion of the formation, the production well configured to produce first hydrocarbons; (d) at least one electrical heater located in the first portion of the formation and/or a second portion of the formation where at least one of the electrical heaters, which is separate from the steam and electricity cogeneration facility, is powered by electricity from the steam and electricity cogeneration facility; (e) at least one further production well located in the first portion of the formation and/or the second portion of the formation where the further production well is configured to produce second hydrocarbons; and (f) a treatment facility for treating the first and/ or second hydrocarbons before use in the steam and electricity cogeneration facility, where the steam and electricity cogeneration facility uses the first and/ or second hydrocarbons to generate electricity.
Patent NZ-574652-A (NZ)
Title: Seismic main beam connection, typically for suspended ceiling panels
Inventor: PLATT WILLIAM J
IPC: E04B1/98
Filed: 2009-02-04
Abstract: In a suspended ceiling for earthquake prone locations, a line of seismic main beam connections of the invention between main beams separates the ceiling into segments that move independently of each other during a quake, to limit a build-up in ceiling momentum. A slotted fishplate in the connection is set to keep the beam ends stable about a gap before a quake, and slidably connected about the gap during a quake.
Patent NZ-580248-A (NZ)
Title: Plants comprising herbicide resistance gene encoding aryloxyalkanoate dioxygenase
Inventor: MERLO DONALD J
IPC: A01H5/00
Filed: 2005-05-02
Abstract: Discloses a method of growing at least one transgenic plant in a field, wherein said method comprises planting of at least one seed of said at least one plant in said field and applying to said field comprising said at least one plant a first herbicide selected from the group comprising a phenoxy auxin herbicide and an aryloxyphenoxypropionate herbicide, wherein said at least one plant comprises a plurality of transgenic plant cells, said cells comprising a polynucleotide that encodes an AAD-1 protein comprising the amino acid sequence of SEQ ID NO: 9 or a variant of SEQ ID NO: 9 wherein said variant has aryloxyalkanoate dioxygenase activity, at least one amino acid deletion or conserved substitution, and at least 95% sequence identity with SEQ ID NO: 9.   Further disclosed is a method of cultivating glyphosate tolerant crop plants in a field, wherein said method comprises planting seeds of said plants in said field and applying a herbicide for controlling glyphosate-resistant weeds in said field of glyphosate tolerant crop plants, wherein said plants comprise a polynucleotide that encodes a protein that enzymatically degrades a herbicide selected from the group comprising a phenoxy auxin and an aryloxyphenoxypropionate, wherein a nucleic acid molecule that encodes said protein hybridizes under stringent conditions with the full complement of a sequence selected from the group comprising SEQ ID NO: 3, SEQ ID NO: 4, and SEQ ID NO:5, wherein said stringent conditions are 1x SSPE and 42°C, and wherein said polynucleotide is operably linked to a promoter that is functional in a plant cell, and said method comprises applying an aryloxyalkanoate herbicide to said field.
Patent NZ-585104-A (NZ)
Title: Underwater foundation for supporting or anchoring wave or tidal energy devices
Inventor: THOMSON ALLAN ROBERT
IPC: E02B9/08
Filed: 2008-10-03
Abstract: A method of installing an underwater foundation, suitable for use in supporting or anchoring wave or tidal energy capture devices is provided. The method comprises providing a foundation unit (1) equipped with a submersible drilling rig (16); placing the foundation unit (1) on the bed of a body of water at a selected location; activating the submersible drilling rig (16) to drill a plurality of pile holes in the bed of the body of water; and securing the foundation unit (1) to the bed of the body of water by means of piles or tendons, inserted in pile holes and secured to the foundation unit (1). A foundation unit (1) and a submersible drilling rig (16) for use in the method are also provided.
Patent NZ-587824-A (NZ)
Title: Novel method for the production of sulphonylpyrroles as hdac inhibitors
Inventor: MULLER MATTHIAS
IPC: C07D403/12
Filed: 2009-03-11
Abstract: Disclosed herein is a process for the preparation of N-sulphonylpyrrole derivatives of formula I, wherein the substituents are as defined within the specification, comprising the step of reacting an acrylic acid chloride compound of formula II' with aqueous hydroxylamine. The process further includes the steps of transforming the compound of formula II into its acid chloride of formula II'.
Patent NZ-590133-A (NZ)
Title: Container and system of use
Inventor: KING GARY WILLIAM
IPC: B65D21/02
Filed: 2011-03-24
Abstract: 590133 Described herein is a container and system of use. The container may be used for storage of recycling materials including a first bin (1) having a first hinged lid (4) and a second bin (10) having a second hinged lid (14) with one or more cooperating sections on the first and second bins allowing the second bin to be mounted to the first bin. The system utilises the container and maintains separation of the material streams during the transport and subsequent processing steps. Separation from source and through subsequent transport and processing may minimise processing costs and avoid contamination and difficulties in processing.
Patent NZ-593271-A (NZ)
Title: Apparatus for testing electrical activity from a biological tissue sample
Inventor: BEST DARRYL JOHN
IPC: G01N27/00
Filed: 2009-11-12
Abstract: 593271 An apparatus (100) for testing electrical activity from a biological tissue sample comprises a body (1) provided with a well (4), stimulating means (8) for stimulating a biological sample located in the well (4), and detecting means (9) for detecting electrical activity in the sample. The apparatus further has a fluid inlet means (10) in fluid communication with the well and a fluid outlet means (16) in fluid communication with the well (4). The inlet means (10) comprises an electrically conductive conduit (11A) which is in fluid contact with a fluid flowing, in use, though the outlet means (16). The outlet means comprises an outlet passage provided in the body, and the electrically conductive conduit extends into the outlet passage. The apparatus can provided with an electrically conductive member (19), which is in electrical contact with a fluid contained, in use, in at least one of the well (4), inlet means (10) and outlet means (16). At least one of the stimulating means and detecting means is engaged with the body by a gripping means which comprises an electrically conductive gripping member which engages the electrically conductive member, and the electrically conductive gripping member is electrically connectable to a data recording system which, in use, records the electrical activity from the sample. Alternatively the outlet means can comprises an upwardly open outlet port in fluid communication with the well, and adjustable fluid level regulation means adapted to draw fluid, in use, from the upwardly open outlet port at a required level and the outlet means can comprises an outlet aperture which is substantially fixed in position relative to the body.
Patent NZ-593649-A (NZ)
Title: Nucleoside analogs
Inventor: BAO DONGHUI
IPC: C07H19/04
Filed: 2009-12-23
Abstract: ABSTRACT - 593649 The disclosure relates to a purified phosphoramidate nucleoside compound represented by formula (II), a salt, a pharmaceutically acceptable salt, a hydrate, a solvate, or a crystalline form thereof, which are suitable for the treatment of any condition the result of an infection by hepatitis C virus, West Nile virus, yellow fever virus, dengue virus, rhinovirus, polio virus, hepatitis A virus, bovine viral diarrhea virus or Japanese encephalitis virus.
Patent NZ-597588-A (NZ)
Title: Removable advanced metering infrastructure cartridge for an energy meter
Inventor: AGRAWAL SACHIN
IPC: G01R1/02
Filed: 2012-01-13
Abstract: Disclosed is an Advanced Metering Infrastructure (AMI) cartridge (30). The cartridge (30) is comprised of an AMI cartridge housing (40) and an AMI module system which is supported within an interior zone (48) of the AMI cartridge housing (40). The AMI module system includes an AMI module and an energy meter interface (52). The energy meter interface (52) is configured and disposed to detachably connect to an energy meter (2).
Patent NZ-598652-A (NZ)
Title: Cancer cell apoptosis
Inventor: YOUNG MALCOLM PHILIP
IPC: A61K31/352
Filed: 2010-09-10
Abstract: 598652 Disclosed is the use of dexanabinol (also known as (6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol), or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the apoptosis of cancer in a patient, wherein the cancer cells are selected from one or more of primary cancer, breast cancer, colon cancer, prostate cancer, non-small cell lung cancer, glioblastoma, lymphoma, mesothelioma, liver cancer, intrahepatic bile duct cancer, oesophageal cancer, pancreatic cancer, stomach cancer, laryngeal cancer, brain cancer, ovarian cancer, testicular cancer, cervical cancer, oral cancer, pharyngeal cancer, renal cancer, thyroid cancer, uterine cancer, urinary bladder cancer, hepatocellular carcinoma, thyroid carcinoma, osteosarcoma, small cell lung cancer, leukaemia, myeloma, gastric carcinoma and metastatic cancers.
Patent NZ-598984-A (NZ)
Title: Hardware to support a oversize door so it will not bow by inter-engagement of co-operating pins and recesses
Inventor: SAUNDERS JOHN DAVID
IPC: E05F7/00
Filed: 2012-03-22
Abstract: Disclosed is an accessory for resisting door flexing or a hinge with protrusions to provide door stiffness and rigidity to reduce strain on the locking mechanism. The accessory comprises a first plate and a substantially flat second plate for attachment to a door or door frame respectively. The first plate having at least one projection adapted to be received in a corresponding recess in the second plate and the door or door frame to which the second plate is attached.
Patent NZ-601418-A (NZ)
Title: Mesh network security system gateway and method
IPC: H04L12/28
Filed: 2008-12-31
Abstract: 601418 Disclosed is a gateway (50) for transmitting signals between a computer network and a radio-frequency mesh network. The gateway (50) is comprised of a housing; a radio-frequency transceiver (50A) for communicating with the radio-frequency mesh network; an Internet Protocol transceiver (50C), operatively coupled to the radio-frequency transceiver (50A), for communicating with the computer network; a power supply (50B); a logic and memory unit (50F) configured to communicate with the computer network using a secure data connection; and a user interface (50G) having at least one of an input and an output. The power supply (50B) includes both a battery and an alternating current power source.
Patent NZ-609963-A (NZ)
Title: Flexible stent
Inventor: BURPEE JANET
IPC: A61F2/82
Filed: 2006-04-04
Abstract: A method for minimizing or eliminating foreshortening of a flexible stent comprises rotating a plurality of side-by-side individual helical elements 18, the helical elements 18 being helically wound about an axis of the stent to form a helical portion 14, the helical portion 14 being expandable radially upon deployment and compressible, expandable and bendable in a deployed state and a strut portion 12 on either side of the helical portion 14. Each of the strut portions 12 comprises axially aligned strut elements 16a having a first end connected to the helical elements 18 of the helical portion 14, the strut portions 16a being radially expandable upon deployment. An axial length of the flexible stent in the deployed state is the same as an axial length of the flexible stent in a crimped state.
Patent NZ-611214-A (NZ)
Title: An electric device and a method for a wave power plant
Inventor: BOSTRÖM Cecilia
IPC: H02M7/02
Filed: 2010-12-09
Abstract: Disclosed is an electric device including a winding, means for inducing a current in the winding and an electrical bridge circuit. The electrical bridge circuit includes capacitor means having a capacitance adapted for obtaining resonance with the inductance of the winding. The bridge circuit includes a first and a second branch connected in parallel to an electric load, the first branch having a first capacitor, the second branch having a second capacitor and a semiconductor. The winding is connected to the second branch in parallel with the second capacitor. The first and second braches are connected to the load by semiconductor means connected in parallel with the first branch.
Patent NZ-611810-A (NZ)
Title: A honey composition and a honey wound dressing
Inventor: WATSON DENIS ERIC
IPC: A61L15/60
Filed: 2009-06-05
Abstract: Disclosed herein is a composition comprising honey, such as Manuka honey, and a super-absorbent polymer fibre, such as OASIS super-absorbent fibre, and the use thereof as a dressing for the treatment of wounds. The composition may be in the form of a semi-solid pliable sheet wherein the sheet comprises at least one layer of a cellulose compressed material, such as tissue paper, or polyester, interspersed with at least one layer of the super-absorbent polymer fibre, the composition optionally coated with a gelling agent.
Patent NZ-622427-A (NZ)
Title: Multipotent stem cells from the extrahepatic biliary tree and methods of isolating same
Inventor: CUI CAI-BIN
IPC: A61K35/413
Filed: 2010-10-28
Abstract: Disclosed is a composition comprising one or more mammalian multipotent stem/progenitor cells capable of differentiating into multiple endodermal lineages, wherein the one or more cells are obtained from biliary tree tissue of a mammal by a method comprising: previously obtaining biliary tree tissue, and sequentially, and in any order, or substantially simultaneously obtaining cells in vitro that are positive for: (i) at least one marker indicative of early liver cell lineage stages; (ii) at least one marker indicative of early pancreatic cell lineage stages; (iii) at least one marker of a pluripotency gene; and optionally, at least one marker selected from (a)-(b): (a) at least one surface marker found on stem/progenitor cells; and (b) at least one transcription factor indicative of endodermal stem/progenitors, and wherein the one or more multipotent stem/progenitor cells capable of differentiating into multiple endodermal lineages do not express markers of mature islet cells or mature liver cells.